Intermittent short‐course anti‐TB regimens vs daily anti‐TB regimens
Treatment‐limiting adverse events · Children with TB1
It is very uncertain whether intermittent short‐course anti‐TB regimens changes treatment‐limiting adverse events compared with daily anti‐TB regimens (very low certainty).
1 finding from 1 review
- Intermittent versus daily therapy for treating tuberculosis in children 2014 · Cochrane Headline outcomes onlyRR 0.4 [0.06, 2.6]4 studies · 441 participantsVery low